表紙
市場調查報告書

全球基因治療市場:細胞類型,載體類型,應用,最終用戶,地區,COVID-19潛在影響的見解和預測(2020-2024年)

Global Gene Therapy Market (by Cell Type, Vector Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版商 Koncept Analytics 商品編碼 954031
出版日期 內容資訊 英文 144 Pages
訂單完成後即時交付
價格
全球基因治療市場:細胞類型,載體類型,應用,最終用戶,地區,COVID-19潛在影響的見解和預測(2020-2024年) Global Gene Therapy Market (by Cell Type, Vector Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
出版日期: 2020年08月17日內容資訊: 英文 144 Pages
簡介

全球基因治療市場預計在2020年至2024年間將以19.29%的複合年增長率增長,到2024年將達到64.2億美元。市場上的關鍵增長因素包括慢性病患病率上升,醫療保健成本增加,城市化進程加快,基因療法的臨床試驗不斷增長以及經濟增長迅速。未來,趨勢將是諸如快速採用個性化醫學,遺傳疾病的發生率增加,基因治療的進展以及研發資金的增加等趨勢。然而,基因治療的副作用,道德和安全問題以及高昂的治療成本是市場面臨的挑戰。

本報告調查了全球基因治療市場,並確定了市場挑戰,增長因素,主要趨勢和發展,預測,COVID-19影響,細胞類型,載體類型,應用,最終用戶,我們提供的信息包括按地區進行的市場分析,競爭狀況以及主要公司的概況。

目錄

第1章市場概述

  • 簡介
  • 基因療法治療的疾病
  • 基因治療過程
  • 基因治療的類型
  • 基因治療的應用
  • 基因治療技術
  • 基因治療的利弊

第2章COVID-19的影響

  • 經濟影響
  • 全球GDP下降
  • 工業和產量下降
  • 對基因治療的影響
  • 基因治療對臨床試驗的影響

第3章世界市場分析(按銷售額)

  • 世界市場
  • 世界市場預測
  • 按單元格類型
    • 體細胞
    • 體細胞預測
    • 生殖細胞
    • 生殖細胞預測
  • 按矢量類型劃分的市場
    • 逆轉錄病毒和Gamma逆轉錄病毒
    • 逆轉錄病毒和Gamma逆轉錄病毒:預測
    • 腺相關病毒
    • 腺相關病毒:預測
    • 慢病毒
    • 慢病毒:預測
    • 腺病毒
    • 腺病毒:預測
    • 改良的單純皰疹病毒
    • 改良型單純皰疹病毒:預測
    • 非病毒質粒載體 [li]非病毒質粒載體:預測
  • 按應用劃分的市場
    • 腫瘤疾病
    • 腫瘤疾病:預測
    • 神經病
    • 神經病:預測
    • 傳染病
    • 傳染病:預測
    • 心血管疾病
    • 心血管疾病:預測
    • 罕見疾病
    • 罕見病:預測
  • 最終用戶的市場
    • 醫院和診所
    • 醫院和診所:預測
    • 專業治療中心
    • 專業治療中心:預測
  • 世界各地區市場

第4章區域市場分析

  • 北美
    • 北美市場
    • 北美市場預測
  • 歐洲
  • 亞太地區
  • 其他地區

第5章市場動態

  • 生長因子
    • 慢性病患病率上升
    • 醫療費用增加
    • 擴大城市化
    • 基因治療臨床試驗的增長
    • 促進經濟增長
  • 主要趨勢與發展
    • 快速採用個性化醫學
    • 遺傳疾病的發病率增加
    • 基因治療的進展
    • 增加研發資金
  • 挑戰
    • 基因治療的副作用
    • 道德和安全問題
    • 治療費用高

第6章競爭情況

  • 世界市場
    • 主要公司的利潤比較
    • 主要公司的市值比較
    • 主要公司之間的研發比較

第7章公司簡介

  • Roche Holding AG
  • Pfizer Inc.
  • Novartis International AG
  • GlaxoSmithKline PLC
  • Bristol Myers Squibb Co. (Celgene Corporation)
  • Gilead Sciences, Inc.
目錄

The global gene therapy market is expected to reach US$6.42 billion in 2024, witnessing growth at a CAGR of 19.29%, over the period 2020-2024. Growth in the gene therapy market has accrued due to the increasing prevalence of chronic diseases, rising healthcare expenditure, expanding urbanization, growth of gene therapy clinical trials and upsurge in economic growth. The market is anticipated to experience certain trends like rapid adoption of personalized medicine, growing occurrence of genetic disorders, advancements in gene therapy and increasing R&D funding. The growth of the market would be challenged by side effects of gene therapy and ethical and safety concerns and high cost of the treatment.

The global gene therapy market has been segmented on the basis of cell type, vector type, application, end-user and region. Depending on the cell type, the market can be bifurcated into somatic cell gene therapy and germ cell gene therapy. According to the vector type, the global gene therapy market can be categorized into retrovirus & gammaretrovirus, adeno-associated viruses (AAV), lentivirus, adenovirus, modified herpes simplex virus and non-viral plasmid vector. Whereas, on the basis of application, the market can be split into oncological disorders, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases and others. Further, in terms of end-user, the global gene therapy market can broadly be segmented into hospitals, specialty treatment centers and other end-users.

The fastest growing regional market is North America due to the rising incidence of cancer and other target diseases, increasing favorable reimbursement scenario in the region and improvements in healthcare infrastructure. Further, the sudden outbreak of COVID-19 is causing an adverse disruption on the overall economy and society, affecting the rate of gene therapy procedures and clinical trials, which is expected to negatively impact the growth of the global gene therapy market during the forecasted period.

Scope of the report:

  • The report provides a comprehensive analysis of the global gene therapy market segmented on the basis of cell type, vector type, application, end-user and region.
  • The major regional and country markets (North America, Europe, Asia Pacific and Rest of the World) have been analyzed.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Pfizer Inc., Novartis International AG, GlaxoSmithKline PLC, Bristol Myers Squibb Co. (Celgene Corporation) and Gilead Sciences, Inc.) are also presented in detail.

Key Target Audience:

  • Gene Therapy Manufacturers
  • End Users (Hospitals, Specialty Treatment Centers & Others)
  • Research Institutes and Organizations
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Diseases Treated by Gene Therapy
  • 1.3 Process of Gene Therapy
  • 1.4 Types of Gene Therapy
  • 1.5 Application Areas for Gene Therapy
  • 1.6 Gene Therapy Techniques
  • 1.7 Advantages & Disadvantages of Gene Therapy

2. Impact of COVID-19

  • 2.1 Economic Impact
  • 2.2 Decline in Global GDP
  • 2.3 Decline in Industrial Production
  • 2.4 Impact on Gene Therapy
  • 2.5 Impact on Clinical Trials of Gene Therapy

3. Global Market Analysis

  • 3.1 Global Gene Therapy Market by Value
  • 3.2 Global Gene Therapy Market Forecast by Value
  • 3.3 Global Gene Therapy Market by Cell Type
    • 3.3.1 Global Somatic Cell Gene Therapy Market by Value
    • 3.3.2 Global Somatic Cell Gene Therapy Market Forecast by Value
    • 3.3.3 Global Germ Cell Gene Therapy Market by Value
    • 3.3.4 Global Germ Cell Gene Therapy Market Forecast by Value
  • 3.4 Global Gene Therapy Market by Vector Type
    • 3.4.1 Global Retrovirus & Gammaretrovirus Gene Therapy Market by Value
    • 3.4.2 Global Retrovirus & Gammaretrovirus Gene Therapy Market Forecast by Value
    • 3.4.3 Global Adeno-Associated Viruses Gene Therapy Market by Value
    • 3.4.4 Global Adeno-Associated Viruses Gene Therapy Market Forecast by Value
    • 3.4.5 Global Lentivirus Gene Therapy Market by Value
    • 3.4.6 Global Lentivirus Gene Therapy Market Forecast by Value
    • 3.4.7 Global Adenovirus Gene Therapy Market by Value
    • 3.4.8 Global Adenovirus Gene Therapy Market Forecast by Value
    • 3.4.9 Global Modified Herpes Simplex Virus Gene Therapy Market by Value
    • 3.4.10 Global Modified Herpes Simplex Virus Gene Therapy Market Forecast by Value
    • 3.4.11 Global Non-Viral Plasmid Vector Gene Therapy Market by Value
    • 3.4.12 Global Non-Viral Plasmid Vector Gene Therapy Market Forecast by Value
  • 3.5 Global Gene Therapy Market by Application
    • 3.5.1 Global Oncological Disorders Gene Therapy Market by Value
    • 3.5.2 Global Oncological Disorders Gene Therapy Market Forecast by Value
    • 3.5.3 Global Neurological Disorders Gene Therapy Market by Value
    • 3.5.4 Global Neurological Disorders Gene Therapy Market Forecast by Value
    • 3.5.5 Global Infectious Disease Gene Therapy Market by Value
    • 3.5.6 Global Infectious Disease Gene Therapy Market Forecast by Value
    • 3.5.7 Global Cardiovascular Diseases Gene Therapy Market by Value
    • 3.5.8 Global Cardiovascular Diseases Gene Therapy Market Forecast by Value
    • 3.5.9 Global Rare Diseases Gene Therapy Market by Value
    • 3.5.10 Global Rare Diseases Gene Therapy Market Forecast by Value
  • 3.6 Global Gene Therapy Market by End-User
    • 3.6.1 Global Hospitals & Clinics Gene Therapy Market by Value
    • 3.6.2 Global Hospitals & Clinics Gene Therapy Market Forecast by Value
    • 3.6.3 Global Specialty Treatment Centers Gene Therapy Market by Value
    • 3.6.4 Global Specialty Treatment Centers Gene Therapy Market Forecast by Value
  • 3.7 Global Gene Therapy Market by Region

4. Regional Market Analysis

  • 4.1 North America
    • 4.1.1 North America Gene Therapy Market by Value
    • 4.1.2 North America Gene Therapy Market Forecast by Value
  • 4.2 Europe
    • 4.2.1 Europe Gene Therapy Market by Value
    • 4.2.2 Europe Gene Therapy Market Forecast by Value
    • 4.2.3 Europe Gene Therapy Market by Indication
    • 4.2.4 Europe Large B-Cell Lymphoma Gene Therapy Market by Value
    • 4.2.5 Europe Large B-Cell Lymphoma Gene Therapy Market Forecast by Value
    • 4.2.6 Europe Inherited Retinal Disease Gene Therapy Market by Value
    • 4.2.7 Europe Inherited Retinal Disease Gene Therapy Market Forecast by Value
    • 4.2.8 Europe ADA-SCID Gene Therapy Market by Value
    • 4.2.9 Europe ADA-SCID Gene Therapy Market Forecast by Value
    • 4.2.10 Europe Acute Lymphoblastic Leukemia Gene Therapy Market by Value
    • 4.2.11 Europe Acute Lymphoblastic Leukemia Gene Therapy Market Forecast by Value
  • 4.3 Asia Pacific
    • 4.3.1 Asia Pacific Gene Therapy Market by Value
    • 4.3.2 Asia Pacific Gene Therapy Market Forecast by Value
  • 4.4 RoW
    • 4.4.1 RoW Gene Therapy Market by Value
    • 4.4.2 RoW Gene Therapy Market Forecast by Value

5. Market Dynamics

  • 5.1 Growth Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Rising Healthcare Expenditure
    • 5.1.3 Expanding Urbanization
    • 5.1.4 Growth of Gene Therapy Clinical Trials
    • 5.1.5 Upsurge in Economic Growth
  • 5.2 Key Trends and Developments
    • 5.2.1 Rapid Adoption of Personalized Medicines
    • 5.2.2 Growing Occurrence of Genetic Disorders
    • 5.2.3 Advancements in Gene Therapy
    • 5.2.4 Increasing R&D Funding
  • 5.3 Challenges
    • 5.3.1 Side Effects of Gene Therapy
    • 5.3.2 Ethical and Safety Concerns
    • 5.3.3 High Cost of Treatment

6. Competitive Landscape

  • 6.1 Global Market
    • 6.1.1 Revenue Comparison of Key Players
    • 6.1.2 Market Capitalization Comparison of Key Players
    • 6.1.3 R&D Comparison of Key Players

7. Company Profiles

  • 7.1 Roche Holding AG
    • 7.1.1 Business Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Business Strategies
  • 7.2 Pfizer Inc.
    • 7.2.1 Business Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Business Strategies
  • 7.3 Novartis International AG
    • 7.3.1 Business Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Business Strategies
  • 7.4 GlaxoSmithKline PLC
    • 7.4.1 Business Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Business Strategies
  • 7.5 Bristol Myers Squibb Co. (Celgene Corporation)
    • 7.5.1 Business Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Business Strategies
  • 7.6 Gilead Sciences, Inc.
    • 7.6.1 Business Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Business Strategies

List of Figures

  • Diseases Treated by Gene Therapy
  • Process of Gene Therapy
  • Types of Gene Therapy
  • Applications Areas for Gene Therapy
  • Gene Therapy Techniques
  • Advantages & Disadvantages of Gene Therapy
  • Breakdown of Direct and Indirect Costs of COVID-19 (2020)
  • Global GDP (2005-2020)
  • Decline in Chinese Industrial Production (2020)
  • Global Most Affected Clinical Trials by Therapy Area (2020)
  • Global Gene Therapy Market by Value (2015-2019)
  • Global Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by Cell Type (2019)
  • Global Somatic Cell Gene Therapy Market by Value (2015-2019)
  • Global Somatic Cell Gene Therapy Market Forecast by Value (2020-2024)
  • Global Germ Cell Gene Therapy Market by Value (2015-2019)
  • Global Germ Cell Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by Vector Type (2019)
  • Global Retrovirus & Gammaretrovirus Gene Therapy Market by Value (2015-2019)
  • Global Retrovirus & Gammaretrovirus Gene Therapy Market Forecast by Value (2020-2024)
  • Global Adeno-Associated Viruses Gene Therapy Market by Value (2015-2019)
  • Global Adeno-Associated Viruses Gene Therapy Market Forecast by Value (2020-2024)
  • Global Lentivirus Gene Therapy Market by Value (2015-2019)
  • Global Lentivirus Gene Therapy Market Forecast by Value (2020-2024)
  • Global Adenovirus Gene Therapy Market by Value (2015-2019)
  • Global Adenovirus Gene Therapy Market Forecast by Value (2020-2024)
  • Global Modified Herpes Simplex Virus Gene Therapy Market by Value (2015-2019)
  • Global Modified Herpes Simplex Virus Gene Therapy Market Forecast by Value (2020-2024)
  • Global Non-Viral Plasmid Vector Gene Therapy Market by Value (2015-2019)
  • Global Non-Viral Plasmid Vector Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by Application (2019)
  • Global Oncological Disorders Gene Therapy Market by Value (2015-2019)
  • Global Oncological Disorders Gene Therapy Market Forecast by Value (2020-2024)
  • Global Neurological Disorders Gene Therapy Market by Value (2015-2019)
  • Global Neurological Disorders Gene Therapy Market Forecast by Value (2020-2024)
  • Global Infectious Disease Gene Therapy Market by Value (2015-2019)
  • Global Infectious Disease Gene Therapy Market Forecast by Value (2020-2024)
  • Global Cardiovascular Diseases Gene Therapy Market by Value (2015-2019)
  • Global Cardiovascular Diseases Gene Therapy Market Forecast by Value (2020-2024)
  • Global Rare Diseases Gene Therapy Market by Value (2015-2019)
  • Global Rare Diseases Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by End-User (2019)
  • Global Hospitals & Clinics Gene Therapy Market by Value (2015-2019)
  • Global Hospitals & Clinics Gene Therapy Market Forecast by Value (2020-2024)
  • Global Specialty Treatment Centers Gene Therapy Market by Value (2015-2019)
  • Global Specialty Treatment Centers Gene Therapy Market Forecast by Value (2020-2024)
  • Global Gene Therapy Market by Region (2019)
  • North America Gene Therapy Market by Value (2015-2019)
  • North America Gene Therapy Market Forecast by Value (2020-2024)
  • Europe Gene Therapy Market by Value (2015-2019)
  • Europe Gene Therapy Market Forecast by Value (2020-2024)
  • Europe Gene Therapy Market by Indication (2019)
  • Europe Large B-cell Lymphoma Gene Therapy Market by Value (2015-2019)
  • Europe Large B-cell Lymphoma Gene Therapy Market Forecast by Value (2020-2024)
  • Europe Inherited Retinal Disease Gene Therapy Market by Value (2015-2019)
  • Europe Inherited Retinal Disease Gene Therapy Market Forecast by Value (2020-2024)
  • Europe ADA-SCID Gene Therapy Market by Value (2015-2019)
  • Europe ADA-SCID Gene Therapy Market Forecast by Value (2020-2024)
  • Europe Acute Lymphoblastic Leukemia Gene Therapy Market by Value (2015-2019)
  • Europe Acute Lymphoblastic Leukemia Gene Therapy Market Forecast by Value (2020-2024)
  • Asia Pacific Gene Therapy Market by Value (2015-2019)
  • Asia Pacific Gene Therapy Market Forecast by Value (2020-2024)
  • RoW Gene Therapy Market by Value (2015-2019)
  • RoW Gene Therapy Market Forecast by Value (2020-2024)
  • Global Cancer Prevalence (2018-2023)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Urban Population (2014-2019)
  • Number of Gene Therapy Clinical Trials Approved Worldwide (2012-2019)
  • Global GDP Per Capita (2014-2019)
  • Global Personalized Medicine Market (2015-2022)
  • Global Sickle Cell Disease Treatment Market (2017-2023)
  • Roche Holding AG Sales and Net Income (2015-2019)
  • Roche Holding AG Sales by Segment (2019)
  • Pfizer Inc. Total Revenue and Profit (2015-2019)
  • Pfizer Inc. Revenue by Segment (2019)
  • Pfizer Inc. Revenue by Region (2019)
  • Novartis International AG Net Sales and Net Income (2015-2019)
  • Novartis International AG Net Sales by Segment (2019)
  • Novartis International AG Net Sales by Region (2019)
  • GlaxoSmithKline PLC Turnover and Profit (2015-2019)
  • GlaxoSmithKline PLC Turnover by Segment (2019)
  • GlaxoSmithKline PLC Turnover by Region (2019)
  • Bristol Myers Squibb Co. Total Revenue and Net Earnings (2015-2019)
  • Bristol Myers Squibb Co. Total Revenue by Region (2019)
  • Gilead Sciences, Inc. Revenue and Net Income (2015-2019)

List of Tables

  • Revenue Comparison of Key Players (2019)
  • Market Capitalization Comparison of Key Players (2020)
  • R&D Comparison of Key Players (2019)